Accelerated UK Clinical Trial Reforms: Enhancin...

By HEOR Staff Writer

November 5, 2025

UK Clinical Trial Reforms Slash Approval Times UK Clinical Trial Reforms have accelerated clinical trial approvals, reducing average times from 91 days to 41 days through risk-proportio...
AI in South African Healthcare: Professionals’ Confidence in Reducing A...
Shifting Toward Sustainable Reimbursement Models in South Africa’s Heal...
Antidepressant Side Effects: New Insights on Cardiometabolic Health Risks
Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 202...
AI Chatbot Delusions: Navigating the Risks of Validation in Mental Health
NICE Endorses Darolutamide Prostate Cancer Treatment for Improved Patient Access
FDA Cancer Trial Guidelines: Prioritizing Overall Survival for Patient-Center...
Fabhalta Kidney Treatment Shows Promise in Slowing Disease Progression for Ig...
Keytruda Lung Cancer Treatment: Long-Term Survival Gains in NSCLC
Promising PSMA-Targeted Therapy Delays Prostate Cancer Progression
Social Media Policy Action: Protecting Youth from Cognitive Risks
Johnson & Johnson Advances Solid Tumor Research at ESMO 2025 with Promis...